Skip to main content

Type 2 diabetes

Browse the latest news, expert commentary, and educational content on type 2 diabetes.


09-04-2021 | Pathophysiology | News

Ethnicity may be independently linked to beta-cell function

Black West African men have lower levels of insulin secretion in response to a meal than their White Northern European counterparts, irrespective of insulin sensitivity, study findings indicate.

08-04-2021 | Stroke | News

Genetic analysis backs causal link between blood glucose and stroke

A Mendelian analysis supports a causal effect of hyperglycemia on stroke risk, and the researchers also pinpoint the medications most likely to reduce this risk.

01-04-2021 | COVID-19 | News

Diabetes medications unlikely to greatly influence COVID-19 mortality risk

Research shows that COVID-19 mortality risk in people with type 2 diabetes varies only a little according to which antiglycemic medications they are taking at the time.

Semaglutide for weight loss: The STEP and SELECT trials

Get the latest results and insights from the researchers.

More on type 2 diabetes

View from the clinic: Sanjay Kalra

Expert insights on identifying appropriate patient profiles when considering the use of medication combinations.

SGLT2 inhibitor use in type 2 diabetes management

Learn about prescribing these medications with guidance from the Improving Diabetes Steering Committee.

  • » A prescribing tool to inform prescribing decisions for SGLT2 inhibitors
  • » SGLT2 inhibitors: Key evidence and implications for clinical practice
  • » Translating SGLT2 inhibitor cardiovascular evidence into practice
  • » This content is intended only for UK healthcare providers and was made possible by educational funding provided by Napp Pharmaceuticals Ltd.

Stay informed with Medicine Matters

Get the latest developments in diabetes delivered straight to your inbox

Image Credits